About: Bob Löwenberg

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Bob Löwenberg Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) 研究者 (ja) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky)
rdfs:label	B. Löwenberg (cs) Bob Löwenberg (en) Bob Löwenberg (nl)
skos:prefLabel	B. Löwenberg (cs) Bob Löwenberg (en) Bob Löwenberg (nl)
name	B. Löwenberg (cs) Bob Löwenberg (en) Bob Löwenberg (nl)
given name	wds:Q71513060-06AA663E-76AB-4504-BAEF-C825B7EF2C85
given name	Bob
instance of	wds:Q71513060-94285937-7D2C-4B4F-9035-5A133C8C73B4
NL CR AUT ID	wds:Q71513060-57A5FCB1-F7A0-4CD7-9F5A-789F59A53FB2
instance of	Homo sapiens
NL CR AUT ID	nlk20040160840
Google Knowledge Graph ID	wds:Q71513060-EA3DDC89-B69E-4EFD-99A8-BB671617F620
MR Author ID	wds:Q71513060-7a0a364c-4277-d0d2-c872-b5e1b6cfbf27
Google Knowledge Graph ID	http://g.co/kg/g/113qpf3ms
Google Knowledge Graph ID	/g/113qpf3ms
MR Author ID	982165
occupation	wds:Q71513060-B380ABA7-CB97-45A8-8DB6-C55C43726A8B
employer	wds:Q71513060-571121F3-3BDF-4091-98B2-FB3984B8825E wds:Q71513060-F6E585B3-B126-4A88-A1B2-86760B1EFA74
NUKAT ID	wds:Q71513060-D5D71714-529A-443B-9745-09CF2916E77A
sex or gender	wds:Q71513060-4F78720E-1F5B-465C-AA2F-647602526DE4
ISNI	wds:Q71513060-1CE35B50-472F-482D-BD9F-1DF7158886EC
VIAF ID	wds:Q71513060-516D8D03-6101-46BB-9EAC-35AF1F0F1D6D
GND ID	wds:Q71513060-df672579-3594-40a8-9c29-3bf6d1900fc1
Library of Congress authority ID	wds:Q71513060-A2127A7F-988D-4D72-AC02-953FA3452427
Bibliothèque nationale de France ID	wds:Q71513060-D0224EEF-7F69-4E77-8522-906FA9B76C4D
IdRef ID	wds:Q71513060-7B0528A5-17BC-48D7-BE59-DB574D73E4AB
BNB person ID	wds:Q71513060-5AE3B1A7-AA8A-4802-9E31-29173BB06FA9
date of birth	wds:Q71513060-F0DD0DCE-FF52-4FE5-A3D9-90FF22302545
family name	wds:Q71513060-17f05ae5-49d9-5646-427b-986eb486c141
National Library of Israel J9U ID	wds:Q71513060-34DDA394-51E9-4768-AFDF-1DF25A3ADBC7
VIAF ID	http://viaf.org/viaf/84865347
GND ID	https://d-nb.info/gnd/1166813606
Library of Congress authority ID	http://id.loc.gov/authorities/names/n82223646
Bibliothèque nationale de France ID	http://data.bnf.fr/ark:/12148/cb15041829v#about
IdRef ID	http://www.idref.fr/077194373/id
BNB person ID	https://bnb.data.bl.uk/doc/person/L%C3%B6wenbergB(Bob)1946-
occupation	researcher
employer	Erasmus MC
NUKAT ID	n2005145713
sex or gender	male
ISNI	0000000109208498
VIAF ID	84865347
GND ID	1166813606
Library of Congress authority ID	n82223646
Bibliothèque nationale de France ID	15041829v
IdRef ID	077194373
BNB person ID	LöwenbergB(Bob)1946-
date of birth	1946-01-01 00:00:00Z (xsd:dateTime)
family name	Löwenberg
National Library of Israel J9U ID	987007375947605171
ORCID iD	wds:Q71513060-ED85B6C9-E436-4B37-9FE6-147BDD2E9C46
ORCID iD	https://orcid.org/0000-0001-8982-5217
ORCID iD	0000-0001-8982-5217
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71513060 Bob Löwenberg
is author of	Differential regulation of Foxo3a target genes in erythropoiesis Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia High-dose daunorubicin in older patients with acute myeloid leukemia Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome Acute myeloid leukemia: the challenge of capturing disease variety Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. PBX3 is an important cofactor of HOXA9 in leukemogenesis miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia HeatMapper: powerful combined visualization of gene expression profile correlations, genotypes, phenotypes and sample characteristics A phase I first-in-human study with tefinostat - a monocyte/macrophage targeted histone deacetylase inhibitor - in patients with advanced haematological malignancies Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Integrative prognostic risk score in acute myeloid leukemia with normal karyotype Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1 Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia Prognostically useful gene-expression profiles in acute myeloid leukemia. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software